ZDA
TDOC icon

Zweig-DiMenna Associates’s Teladoc Health TDOC Stock Holding History

Zweig-DiMenna Associates’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-93,541
Closed -$8.59M – 142
2021
Q4 		$8.59M Sell
93,541
-5,657
-6% -$676K 0.69% 61
2021
Q3 		$12.6M Hold
99,198
– – 0.87% 44
2021
Q2 		$16.5M Hold
99,198
– – 0.99% 33
2021
Q1 		$18M Sell
99,198
-20,470
-17% -$4.75M 1.25% 25
2020
Q4 		$23.9M Sell
119,668
-26,917
-18% -$5.47M 1.52% 17
2020
Q3 		$32.1M Buy
146,585
+32,130
+28% +$6.8M 2.18% 7
2020
Q2 		$21.8M Buy
+114,455
New +$20.1M 2.3% 8

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Zweig-DiMenna Associates's TDOC Position: Q1 2022 in Review

Zweig-DiMenna Associates sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 93,541 shares — an estimated $8.59M sold.

Zweig-DiMenna Associates first reported a position in TDOC in Q2 2020 and held it in 7 quarters. The position peaked at $32.1M in Q3 2020. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • Zweig-DiMenna Associates reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • Zweig-DiMenna Associates sold 93,541 Teladoc Health shares in Q1 2022, an estimated $8.59M.
  • Zweig-DiMenna Associates first reported a position in Teladoc Health in Q2 2020 and held it in 7 quarters.
  • Zweig-DiMenna Associates's Teladoc Health position peaked at $32.1M in Q3 2020.
  • 680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Zweig-DiMenna Associates's 13F filing for Q1 2022, filed 25 Apr 2022.